33 results
8-K
EX-1.1
KPRX
Kiora Pharmaceuticals Inc
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
. At least one member of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules … , at least one member of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules
8-K
EX-1.1
bykqhwza 0o
26 Jul 22
Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering
4:31pm
8-K
69v2v8yspqefqqk3ok
1 Apr 21
EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Directors
6:55am
8-K
EX-10.1
v9g 6p2pb79
1 Feb 21
Departure of Directors or Certain Officers
6:55am